Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

about

A case of neuroendocrine carcinoma expressing myeloid markers by flow cytometry and review of the literature.CD200 Expression in Neuroendocrine Neoplasms.

P2860

Q38859049-8C7DABC5-6E59-455C-98BE-4905463A4C31 Q51805000-0A1C0AD2-393C-4DCC-A4C5-F995AE5FF236

P2860

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

Item

http://www.wikidata.org/entity/Q38941113

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

@en

type

Item

label

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

@en

prefLabel

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

@en

P1476

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

@en

P2093

Evan Davis

http://www.w3.org/2001/XMLSchema#string

Jason Love

http://www.w3.org/2001/XMLSchema#string

Kimberly Thompson

http://www.w3.org/2001/XMLSchema#string

Sandra D Bohling

http://www.w3.org/2001/XMLSchema#string

Steven J Kussick

http://www.w3.org/2001/XMLSchema#string

P2860

CD200-expressing human basal cell carcinoma cells initiate tumor growth

CD200 expression in patients with Multiple Myeloma: another piece of the puzzle.

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

CD200 and membrane protein interactions in the control of myeloid cells.

New markers for minimal residual disease detection in acute lymphoblastic leukemia.

PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.

Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma

Immune modulation by melanoma and ovarian tumor cells through expression of the immunosuppressive molecule CD200.

Cancer stem cells, CD200 and immunoevasion.

CD200 expression on tumor cells suppresses antitumor immunity: new approaches to cancer immunotherapy.

P304

493-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.B.21340

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26584149

http://www.w3.org/2001/XMLSchema#string

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

about

P2860

P2860

Flow cytometric analysis of CD200 expression by pulmonary small cell carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698